Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of liver cirrhosis
Wen-Ce Zhou
World Journal of Gastroenterology (2014) Vol. 20, Iss. 23, pp. 7312-7312
Open Access | Times Cited: 552

Showing 1-25 of 552 citing articles:

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 865
Hypoxia signaling in human diseases and therapeutic targets
Jae W. Lee, Junsuk Ko, Cynthia Ju, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 6, pp. 1-13
Open Access | Times Cited: 330
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine
Kívia De Andrade, Fabiana Andréa Moura, John Marques dos Santos, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 12, pp. 30269-30308
Open Access | Times Cited: 222
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
Chathur Acharya, Sinem E. Sahingur, Jasmohan S. Bajaj
JCI Insight (2017) Vol. 2, Iss. 19
Open Access | Times Cited: 208
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D’souza, Keith C.K. Lau, Carla S. Coffin, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 38, pp. 5759-5783
Open Access | Times Cited: 190
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Leen Heyens, Dana Busschots, Ger H. Koek, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 169
<p>The Toxicity Of Metallic Nanoparticles On Liver: The Subcellular Damages, Mechanisms, And Outcomes</p>
Yao Ying, Yiteng Zang, Jing Qu, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 8787-8804
Open Access | Times Cited: 160
Stiff matrix induces exosome secretion to promote tumour growth
Bin Wu, Di-Ao Liu, Lei Guan, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 3, pp. 415-424
Open Access | Times Cited: 132
A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer
Chen Yang, Hailin Zhang, Mengnuo Chen, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 115
Liver Fibrosis: A Compilation on the Biomarkers Status and Their Significance During Disease Progression
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, V Lakshmaiah, et al.
Future Science OA (2017) Vol. 4, Iss. 1
Open Access | Times Cited: 148
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
Joanne O’Rourke, Vandana Sagar, Tahir Shah, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 39, pp. 4436-4447
Open Access | Times Cited: 131
Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities
P. M. Lam, Fan Cheung, Hor‐Yue Tan, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 4, pp. 465-465
Open Access | Times Cited: 128
Nanoparticles for the treatment of liver fibrosis
Suchithra Poilil Surendran, Reju George Thomas, Myeong-Ju Moon, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 6997-7006
Open Access | Times Cited: 122
Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
Chenxia Hu, Lingfei Zhao, Lingjian Zhang, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 113
Isotopic analysis of Cu in blood serum by multi-collector ICP-mass spectrometry: a new approach for the diagnosis and prognosis of liver cirrhosis?
Marta Costas‐Rodríguez, Yulia Anoshkina, Sara Lauwens, et al.
Metallomics (2015) Vol. 7, Iss. 3, pp. 491-498
Open Access | Times Cited: 101
Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
Paria Zarghamravanbakhsh, Michael Frenkel, Leonid Poretsky
Metabolism Open (2021) Vol. 12, pp. 100149-100149
Open Access | Times Cited: 89
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
Tomoko Tadokoro, Asahiro Morishita, Tsutomu Masaki
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8139-8139
Open Access | Times Cited: 60
Modelling metabolic diseases and drug response using stem cells and organoids
Wenxiang Hu, Mitchell A. Lazar
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 12, pp. 744-759
Open Access | Times Cited: 60
From MAFLD to hepatocellular carcinoma and everything in between
Sarah Da Won Bae, Jacob George, Liang Qiao
Chinese Medical Journal (2022) Vol. 135, Iss. 5, pp. 547-556
Open Access | Times Cited: 48
The detrimental effects of micro-and nano-plastics on digestive system: An overview of oxidative stress-related adverse outcome pathway
Ruiyang Ding, Yiming Ma, Tianyu Li, et al.
The Science of The Total Environment (2023) Vol. 878, pp. 163144-163144
Closed Access | Times Cited: 29
Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
Minni Zhang, Kun Liu, Qiuyue Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Depression-like phenotypes in mice following common bile duct ligation: Insights into the gut–liver–brain axis via the vagus nerve
Yong Yang, Akifumi Eguchi, Chisato Mori, et al.
Neurobiology of Disease (2024) Vol. 192, pp. 106433-106433
Open Access | Times Cited: 11
A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms
Fei Xiong, Yichen Zhang, Ting Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Advances, challenges and future applications of liver organoids in experimental regenerative medicine
Da Gong, Jian Mo, Mei Zhi Zhai, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top